InsiderPulse
← 10-K / 10-Q
10-QMGRX

MANGOCEUTICALS, INC.

Filed 2026-05-19Period ending 2026-03-31
EDGAR ↗All periods →

Income Statement

Line Item2026-03-31Q/QY/Y
Revenue$68K-37.9%
Cost of Revenue$8K-66.8%
Gross Profit$29K-53.3%
SG&A Expense$1.1M-31.7%
Operating Income-$3.1M+35.6%
Pre-tax Income-$3.4M+29.7%
Net Income-$3.4M+29.7%
EPS (Basic)-$0.22+82.9%
EPS (Diluted)-$0.22+82.9%

Balance Sheet

Line Item2026-03-31Q/QY/Y
Cash & Equivalents$175K-88.3%+128.2%
Current Assets$212K-86.3%+20.3%
Total Assets$14.4M-10.2%-33.6%
Current Liabilities$738K-17.2%-50.9%
Total Liabilities$975K+9.4%-35.2%
Stockholders' Equity$13.5M-11.3%-33.5%

Cash Flow

Line Item2026-03-31Q/QY/Y
Operating Cash Flow-$1.3M+42.4%
Financing Cash Flow$2.3M+0.0%